Find and Join

News Logo

• Tattoos, legal counsel, and good info

  If APC had a tattoo on its bicep — if we had a bicep, I mean — it might well read “Consult legal counsel.” read more →

• State advocacy update

  APC sent a letter to the New Mexico Board of Pharmacy this week commenting on its proposed amendments that would align the state with USP (good), but would also require that pharmacists ensure all flavors are inert (yikes). read more →

• Board approves new officer succession

  The APC Board of Directors has voted to name Gina Besteman (previously vice president) the board chair-elect after the resignation of Michelle Moser from the position. Besteman will assume the chair in January 2025. read more →

• FDA is concerned about compounded GLP-1 dosing errors

  Earlier this week APC received a letter from the FDA explaining the agency's concerns regarding dosing and patient usage of compounded semaglutide and tirzepatide. read more →

• Did you get your Compounding Pharmacy Snapshot?

  If you haven’t already, don’t forget to download and share the 2023-2024 edition of our Snapshot of Pharmacy Compounding in America. read more →

• After report, FTC to sue PBMs

  On Tuesday, the Federal Trade Commission released a scathing, two-years-in-the-making report about PBMs. read more →

More News

PCCA Ad

Blank

Medisca Ad

Blank

Fagron Ad

Blank

Wedgewood Ad

Blank

TopiClick Ad

It’s called “Quality, Speed & Equity: Delivering COVID-19 Vaccines to the World” and it’s this Monday, March 15, 10:30am to noon EDT.

Experts from organizations central to vaccine development and delivery, regulatory oversight and quality assurance will discuss over the course of two high-level panels what’s needed for the global COVID-19 vaccination campaign, how to build public trust in the quality and effectiveness of vaccines, and how these investments can build better systems for the future.